AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
MRX

Marex Group plc Ordinary Shares (MRX) fair value

Financial Services · Capital Markets · NASDAQ · United States
$69.96+2.07%
Market cap $5.0BNext earnings 2026-11-05Updated Oct 16, 2026
Add earnings to calendarGoogle
Our verdict
Trades 6% below our fair value
Price
$69.96
Model fair valueConfidence: good
$74.44
Model range
$72.52 to $76.09
Fair value $74.44
Price $69.96
2 models fit Marex Group plc Ordinary Shares and they agree: 2 of 2 land within 15% of the average. The price is below every model.
Two or more of our models back this value.
Near fair value(i)Gold85
Valued as an asset manager: P/E comparison and Residual income.
ACCE opinionMarex Group plc Ordinary Shares (MRX)
Fair value (2 models)
$74.44
ACCE price target
$84.00
Rating
Fairly valued
Horizon
12 months
Fair value published on 12 Oct 2026, 00:00 CEST; previously $48.32 since 28 Sept 2026, 00:00 CEST.
ACCE price target published on 10 Oct 2026, 00:00 CEST.
Price used: $69.96 at the close on 23 Oct 2026, 22:00 CEST.
Models: P/E comparison and Residual income.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
Price vs fair value
6.0% below
+6.4% to fair value
ACCE score
91
out of 100
Analysts
89% buy
9 covering
P/E
14.1x
forward 10.5x
1-year return
+130.7%
Dividend yield
0.93%

Marex Group plc Ordinary Shares in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Marex Group is a London-listed financial intermediary that earns commissions and interest on clearing, execution and market-making in futures, options, OTC derivatives, securities and physical commodities for institutional and professional clients. Its moat is a mix of scale in clearing relationships and a broad product set that makes it hard for clients to switch, and the fee-and-spread model with a 70% gross margin is structurally more durable than balance-sheet trading. Revenue growth of 32.1% is the headline, and it is the kind of rate that tends to follow when volatility and client volumes rise across several markets at once, so the question for a PM is how much of that is cyclical tailwind versus share gains. At 14.6 times trailing earnings and 7.2 times forward, the market is pricing a sharp earnings step-down or doubting the forecasts, which makes the gap between the two multiples the first thing to test. With a 26.2% return on equity and 17.2% operating margin, the business already converts capital efficiently, so the deeper look should focus on whether the forward estimates hold through a softer trading environment.

AI-assisted·How I use AIWritten Oct 18, 2026
⚠ Investor warnings · 2 flagsAI-assisted·How I use AI
  • moderate
    Insider selling without buying
    Insiders disclosed $3.50M in sales across the last 10 filings and no purchases. Insider ownership is 6.8%, so the signal is weak but worth tracking.
  • moderate
    High leverage on the balance sheet
    Debt/Equity is 8.10. For a capital markets firm with $654M of free cash flow the ratio is high, so a downturn in trading volumes would hit equity harder than the earnings line.

AI research notes

AI-assisted·How I use AIWritten Oct 23, 2026 · figures from 2026-06-30 · prices to Oct 23, 2026
Why it could do well
  • Revenue grew 32.1% year over year, and has averaged 36.8% growth per year over five years.
  • Free cash flow over the last twelve months reached $654M, a 12.2% yield at the current share price.
Why it could disappoint
  • Debt is 8.10 times equity, which magnifies losses if trading conditions turn against the firm.
  • Return on invested capital is only 2.2%, far below the 26.2% return on equity.
  • Part of the recent revenue jump comes from volatile trading gains that may not repeat.
Each chip shows the exact figure and where it comes from. A claim without a source is not published.

Next results

Nov 5, 2026
We update the fair value about 2 days after the results, once the new figures are filed.Add to calendarGoogle

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where MRX's valuation models land
Price
$69.96
Model fair value
$74.44
Model range
$72.52 to $76.09
Fair value $74.44
Price $69.96
The price is below the whole model range.
Model
Fair value
Upside
P/E comparison
Residual income
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

Bullish89% buy · 9 covering analysts
● Strong buy 5● Buy 3● Hold 1● Sell 0● Strong sell 0
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Press releases mentioning this company

Recent performance

1 week
-0.8%
1 month
-2.3%
3 months
+6.7%
6 months
+32.5%
YTD
+82.4%
1 year
+130.7%

SEC filings

Recommendation history, last 12 months

DateTypeNewPreviousPrice
12 Oct 2026, 00:00 CESTFair value$74.49$48.32$71.92
10 Oct 2026, 00:00 CESTACCE price target$84.00first publication$71.17
28 Sept 2026, 00:00 CESTFair value$48.32$48.92$71.31
26 Sept 2026, 00:00 CESTFair value$48.92$50.15$72.69
23 Sept 2026, 00:00 CESTFair value$50.15$51.46$75.71
18 Sept 2026, 00:00 CESTFair value$51.46$52.10$72.38
12 Sept 2026, 00:00 CESTFair value$52.10$53.73$74.09
7 Sept 2026, 00:00 CESTFair value$53.73$51.41$78.27
4 Sept 2026, 00:00 CESTFair value$51.41$52.03$71.67
30 Aug 2026, 00:00 CESTFair value$52.03$52.99$72.84

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full MRX page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth100Value92Quality75Momentum97Total91
Valuation
Trailing P/E
14.1x
Forward P/E
10.5x
PEG
0.14
P/B
2.75x
EV / Revenue
1.9x
Book value/sh
$18.94
Enterprise value
$8.2B
Profitability
ROE
26.2%
FCF yield
12.23%
ROIC
2.2%
Health and risk
Debt / equity
8.10
Dividend yield
0.93%
Beta
-0.02

Price

+128.8% · 1Y

Ask anything about MRX

Answered from Marex Group plc Ordinary Shares fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
P/Ebetter than 83% of peers
low 0.0x14.1xhigh 29.7x
ROEbetter than 80% of peers
low -1212%26%high 38%
Div yieldbetter than 83% of peers
low 0.0%0.9%high 1.9%

Peers

Prices Oct 23, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
MRX Marex Group plc Ordinary Shares$69.96$746% below14.1x26.2%7591
FIGR Figure Technology Solutions Inc. Class A Common Stock$24.04$1831% above27.3x26.1%9663
BGC BGC Group Inc. Class A Common Stock$11.89$926% above29.7x15.9%6268
WULF TeraWulf Inc. Common Stock$11.32----1211.8%2918
MKTX MarketAxess Holdings Inc. Common Stock$164.66$8985% above19.5x23.1%9559
MOTILALOFS.NS Motilal Oswal Financial Services Limited₹977.00--28.7x-8170
PJT PJT Partners Inc. Class A Common Stock$142.85--18.6x37.6%8168

Sector report card

Where MRX ranks against its sector peers on each metric.

Computing percentiles…
  • GlobeNewswire•Oct 13, 2026
    Marex Group Limited to announce third quarter 2026 results on November 5, 2026
  • GlobeNewswire•Oct 7, 2026
    Marex announces changes to Group Board
  • GlobeNewswire•Aug 12, 2026
    Marex Group Limited announces second quarter 2026 results
5 more press releases · full archive on Investor+.INVESTOR
40 filings
October 2026
Oct 14
Form 4Insider transactionPeriod 2026-10-12
View on SEC →
Oct 14
Form 4Insider transactionPeriod 2026-10-12
View on SEC →
Oct 7
6-KForeign current reportPeriod 2026-10-07
View on SEC →
37 more filings + AI summaries on Investor+.INVESTOR